Dr. Dinwoodie is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12902 Usf Magnolia Dr
Mdc 44
Tampa, FL 33612Phone+1 813-745-3980Fax+1 813-745-7229
Education & Training
- University of South Florida MorsaniFellowship, Hematology and Medical Oncology, 1977 - 1978
- University of South Florida MorsaniResidency, Internal Medicine, 1973 - 1977
- HCA Florida Healthcare/USF Morsani College of Medicine GME St Petersburg HospitalInternship, Transitional Year, 1972 - 1973
- Indiana University School of MedicineClass of 1972
Certifications & Licensure
- IN State Medical License 1972 - 2025
- FL State Medical License 1974 - 2017
Clinical Trials
- A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal Carcinoma Start of enrollment: 2001 Nov 01
Publications & Presentations
PubMed
- 32 citationsCarboplatin and paclitaxel treatment is effective in advanced anal cancer.Richard D. Kim, Jennifer Byer, William J. Fulp, Amit Mahipal, William R. Dinwoodie
Oncology. 2014-01-01 - 61 citationsIntensity-Modulated Radiation Therapy vs. 3D Conformal Radiation Therapy for Squamous Cell Carcinoma of the Anal Canal.Chuong, J. Freilich, Sarah E. Hoffe, William J. Fulp, Jill Weber
Gastrointestinal Cancer Research. 2013-03-01 - 6 citationsPhase I Study of the Taxane BMS-188797 in Combination with Carboplatin Administered Every 3 Weeks in Patients with Solid MalignanciesMayer Fishman, Christopher R. Garrett, George R. Simon, Alberto Chiappori, Richard Lush
Clinical Cancer Research. 2006-01-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: